| Sector: |
Healthcare |
| Industry: |
Biotechnology |
| Exchange: |
NASDAQ |
| Last Open: |
230.61 |
| Day Range: |
229.35 - 234.87 |
| Last Close: |
232.62 |
| Change: |
1.95 (0.01%) |
| Volume: |
665,904 |
| Avg Vol (3m): |
1,430,700 |
| 52wk Range: |
126.39 - 217.80 |
| Market Cap: |
55,681,000,000 |
| EBITDA: |
2,344,000,000 |
| P/E Ratio: |
36.91 |
|
(BIIB) DIVIDEND RATINGS:
| Overall Rating: |
N/A |
| The overall rating is a weighted average of the three other rated categories listed below. It is a general indication of the health of a dividend. |
| Rating last changed: N/A |
|
| Dividend Yield: |
N/A |
| This indicator measures a stock's current dividend yield, and compares it to similar stocks and historical yields. |
| Dividend History: |
5
Excellent
|
| The rating for dividend history is determined by looking back at the frequency and amount of historical dividend payments. |
| Dividend Increases: |
5
Excellent
|
| This indicator measures a stock's history of dividend increases; consistent increases over time will produce a favorable rating. |
Learn More About Our Ratings
|
HEADLINES FOR (BIIB):
OTHER BIOTECHNOLOGY COMPANIES:
|